eMedicine Specialties > Ophthalmology > Cornea

Keratoconus

Author: Barry A Weissman, OD, PhD, FAAO, Chief of Contact Lens Service, Professor, Department of Ophthalmology, Jules Stein Eye Institute, University of California at Los Angeles
Coauthor(s): Karen K Yeung, OD, FAAO, Director of Optometry, Arthur Ashe Student Health and Wellness Center, University of California at Los Angeles
Contributor Information and Disclosures

Updated: Jan 8, 2007

Introduction

Background

Keratoconus (KC) is a progressive, noninflammatory, bilateral (but usually asymmetrical) disease of the cornea, characterized by paraxial stromal thinning that leads to corneal surface distortion. Visual loss occurs primarily from irregular astigmatism and myopia and secondarily from corneal scarring.

Pathophysiology

All layers of the cornea are believed to be affected by KC, although the most notable features are the thinning of the corneal stroma, the ruptures in the Bowman layer, and the deposition of iron in the basal epithelial cells, forming the Fleischer ring. Breaks in and folds close to the Descemet membrane result in acute hydrops and striae, respectively.

Frequency

United States

Reported prevalence in the general population varies (50-200 per 100,000), perhaps with differences in diagnostic criteria. It is commonly an isolated ocular condition but sometimes coexists with other ocular and systemic diseases.

Commonly recognized ocular associations include vernal keratoconjunctivitis, retinitis pigmentosa, and Leber congenital amaurosis; systemic putative associations include many of the connective tissue disorders (eg, Ehlers-Danlos and Marfan syndromes), mitral valve prolapse, atopic dermatitis, and Down syndrome.

Particular risk factors include atopic history, especially ocular allergies, rigid contact lens (CL) wear, and vigorous eye rubbing.

Most KC cases appear spontaneously, although approximately 14% of them present with evidence of genetic transmission.

International

Anecdotal reports suggest an increase in prevalence in some parts of the world, Arabia, the Indian subcontinent, and New Zealand.

Mortality/Morbidity

  • Because few elderly patients have been noted with KC, many wonder if KC is associated with some fatal disease. However, several recent studies provide compelling evidence that KC does not result in increased mortality.
  • Advanced KC rarely may progress to corneal hydrops, the so-called acute keratoconus, wherein breaks occur in the Descemet layer, which lead to central stromal edema and potentially secondary severe corneal scarring. Patients report sudden loss of vision and some ocular discomfort in one eye but usually not much pain or conjunctival injection. Acute treatment of hydrops is palliative; many corneas flatten secondary to hydrops, and both visual acuity and CL application may improve following such events. If secondary scarring is severe, corneal transplantation (penetrating keratoplasty [PKP]) may be warranted.
  • PKP is otherwise indicated when CLs and intrastromal plastic rings (Intacs) are either no longer tolerated or no longer useful in vision correction. When good CL care is available, only 10-20% of patients with KC eventually require PKP. The need for PKP increases when optimal CL care is not available, but many patients still require CL care for optimum visions following PKPs.

Sex

An equal incidence of KC occurs in males and females.

Age

  • KC typically presents at puberty and progresses until the third and fourth decades of life, although it can occur or progress at any age.
  • KC progresses at various rates but tends to progress more rapidly in young patients.

Clinical

History

  • Patients often report decreasing vision (distortions, glare/flare, and monocular diplopia or ghost images) with multiple unsatisfactory attempts in obtaining optimum spectacle correction.
  • Soft contact lenses and spectacles may initially give satisfactory vision, but vision tends to decline over time and requires rigid gas permeable (RGP) contact lenses for correction.

Physical

KC is divided into mild, moderate, and advanced.

  • Mild KC
    • External/corneal signs - Often none or minimal
    • Suspicious signs - History of multiple inadequate spectacle corrections of one or both eyes, which may include oblique astigmatism on refraction as well as moderate-to-high myopia.
    • Irregularly astigmatic keratometry values (egg-shaped), not necessarily on the steep side of normal (approximately 45 diopters [D]), are consistent with diagnosis.
    • Diagnosis can be confirmed with corneal topography, which may reveal corneal inferior steepening (approximately 80% of KC cases), central corneal astigmatic steepening (approximately 15% of KC cases), or even bilateral temporal steepening (extremely rare).
    • Diagnosis also may be aided by applying a diagnostic rigid CL with its base curve equal to the flat keratometry value. One observes a typical nipple pattern by use of sodium fluorescein dye in the underlying tear film.
  • Moderate KC
    • Often shows one or more corneal signs of KC
      • Enhanced appearance of the corneal nerves
      • Approximately 40% of eyes with moderate KC develop Vogt striae (fine stress lines) in the deep stroma.
      • Approximately 50% of eyes with moderate KC develop the deposition of iron in the basal epithelial cells in a (often partial) ring shape at the base of the conical protrusion called the Fleischer ring.
      • Approximately 20% of eyes with moderate KC develop corneal scarring.
    • Superficial corneal scarring can be fibular, nebular, or nodular.
    • Deep stromal scarring may occur, perhaps representing resolved mini-hydrops events.
    • Some patients show scarring at the level of the Descemet membrane, consistent in appearance with posterior polymorphous corneal dystrophy.
    • Paraxial (usually inferior to the pupil) stromal thinning may be appreciated.
    • Keratometry values typically increase to 45-52 D.
    • Distortion of the retinoscopy and direct ophthalmoscope red pupillary reflex may allow observation of "scissoring" or an inferior distortion termed the oil drop sign.
    • Munson sign - Upon downgaze, observation of a "V" shape to the cornea's profile against the lower lid margin, an accentuation of the conical shape of the modest to advanced KC cornea
  • Advanced KC
    • Often results in keratometry values greater than 52 D and enhancement of all corneal signs, symptoms, and visual loss/distortion.
    • Vogt striae are seen in approximately 60% of eyes, and both Fleischer ring and/or scarring are seen in approximately 70% of eyes.
  • Acute corneal hydrops can occur.

Causes

  • Although not definitively identified, genetic inheritance; systemic and ocular associations; eye rubbing; atopy, specifically ocular allergies; and CL wear are proposed risk factors.
  • Several reports suggest, perhaps coincidentally, associations with KC and other corneal dystrophies.

More on Keratoconus

Overview: Keratoconus
Differential Diagnoses & Workup: Keratoconus
Treatment & Medication: Keratoconus
Follow-up: Keratoconus
Multimedia: Keratoconus
References

References

  1. Boxer Wachler BS, Christie JP, Chandra NS, et al. Intacs for keratoconus. Ophthalmology. May 2003;110(5):1031-40. [Medline].

  2. Karseras AG, Ruben M. Aetiology of keratoconus. Br J Ophthalmol. Jul 1976;60(7):522-5. [Medline].

  3. Kennedy RH, Bourne WM, Dyer JA. A 48-year clinical and epidemiologic study of keratoconus. Am J Ophthalmol. Mar 15 1986;101(3):267-73. [Medline].

  4. Korb DR, Finnemore VM, Herman JP. Apical changes and scarring in keratoconus as related to contact lens fitting techniques. J Am Optom Assoc. Mar 1982;53(3):199-205. [Medline].

  5. Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol. Jan-Feb 1984;28(4):293-322. [Medline].

  6. Lass JH, Lembach RG, Park SB, et al. Clinical management of keratoconus. A multicenter analysis. Ophthalmology. Apr 1990;97(4):433-45. [Medline].

  7. Macsai MS, Varley GA, Krachmer JH. Development of keratoconus after contact lens wear. Patient characteristics. Arch Ophthalmol. Apr 1990;108(4):534-8. [Medline].

  8. Maeda N, Klyce SD, Smolek MK. Comparison of methods for detecting keratoconus using videokeratography. Arch Ophthalmol. Jul 1995;113(7):870-4. [Medline].

  9. Maguire LJ, Bourne WM. Corneal topography of early keratoconus. Am J Ophthalmol. Aug 15 1989;108(2):107-12. [Medline].

  10. Moodaley L, Buckley RJ, Woodward EG. Surgery to improve contact lens wear in keratoconus. CLAO J. Apr 1991;17(2):129-31. [Medline].

  11. Moodaley LC, Woodward EG, Liu CS, Buckley RJ. Life expectancy in keratoconus. Br J Ophthalmol. Oct 1992;76(10):590-1. [Medline].

  12. Rabinowitz YS. Keratoconus. Surv Ophthalmol. Jan-Feb 1998;42(4):297-319. [Medline].

  13. Rabinowitz YS, Garbus J, McDonnell PJ. Computer-assisted corneal topography in family members of patients with keratoconus. Arch Ophthalmol. Mar 1990;108(3):365-71. [Medline].

  14. Rabinowitz YS. The genetics of keratoconus. Ophthalmol Clin North Am. Dec 2003;16(4):607-20, vii. [Medline].

  15. Sherwin T, Brookes NH. Morphological changes in keratoconus: pathology or pathogenesis. Clin Experiment Ophthalmol. Apr 2004;32(2):211-7. [Medline].

  16. Vogt A. Reflexlinien durch faltung spiegelnder grenzflachen im bereiche von corneo, linsenkapsel und netzhaut. Albrecht von Graefes Arch Ophthalmol. 1919;99:296-338.

  17. Wilson SE, Lin DT, Klyce SD. Corneal topography of keratoconus. Cornea. Jan 1991;10(1):2-8. [Medline].

  18. Wollensak G. Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol. Aug 2006;17(4):356-60. [Medline].

  19. Zadnik K, Barr JT, Gordon MO, Edrington TB. Biomicroscopic signs and disease severity in keratoconus. Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study Group. Cornea. Mar 1996;15(2):139-46. [Medline].

Further Reading

Keywords

KC, corneal disease, stromal thinning, corneal scarring, irregular astigmatism, myopia, vision loss, Fleischer ring, Descemet membrane, intracorneal plastic rings, Intacs, corneal transplantation, penetrating keratoplasty, PKP, contact lens, contact lenses, CL, CL wear, contact lens wear, eye allergies, ocular allergies, eye rubbing

Contributor Information and Disclosures

Author

Barry A Weissman, OD, PhD, FAAO, Chief of Contact Lens Service, Professor, Department of Ophthalmology, Jules Stein Eye Institute, University of California at Los Angeles
Barry A Weissman, OD, PhD, FAAO is a member of the following medical societies: American Academy of Optometry and Phi Beta Kappa
Disclosure: Nothing to disclose.

Coauthor(s)

Karen K Yeung, OD, FAAO, Director of Optometry, Arthur Ashe Student Health and Wellness Center, University of California at Los Angeles
Karen K Yeung, OD, FAAO is a member of the following medical societies: American Academy of Optometry
Disclosure: Nothing to disclose.

Medical Editor

Fernando H Murillo-Lopez, MD, Senior Surgeon, Unidad Privada de Oftalmologia CEMES
Fernando H Murillo-Lopez, MD is a member of the following medical societies: American Academy of Ophthalmology
Disclosure: Nothing to disclose.

Pharmacy Editor

Simon K Law, MD, PharmD, Assistant Professor of Ophthalmology, Jules Stein Eye Institute; Chief of Section of Ophthalmology Surgical Services, Department of Veterans Affairs Healthcare Center, West Los Angeles
Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Association for Research in Vision and Ophthalmology
Disclosure: Nothing to disclose.

Managing Editor

Christopher J Rapuano, MD, Professor, Department of Ophthalmology, Jefferson Medical College; Co-Chairman of the Cornea Service, Co-Chairman of Refractive Surgery Department, Wills Eye Hospital
Christopher J Rapuano, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, Eye Bank Association of America, Pennsylvania Medical Society, and Philadelphia County Medical Society
Disclosure: Allergan Honoraria Speaking and teaching; Allergan Consulting fee Consulting; Alcon Honoraria Speaking and teaching; Inspire Honoraria Speaking and teaching; RPS Ownership interest Other

CME Editor

Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri
Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences
Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.